← Back
$STOK All transactions

Stoke Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$17K

Shares

850

Price

$20

Filed

Sep 3

Insider

Name

Allan Jonathan

Title

GENERAL COUNSEL & CORP SEC

CIK

0001966716

Roles

Officer

Transaction Details

Transaction Date

2025-08-29

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

23,948

Footnotes

This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2024. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 3 of this Form 4. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.20, inclusive. | The option vested or vests as to 1/48th of the total award on January 7, 2023, with 1/48th of the total award vesting monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date.

Filing Info

Accession No.

0001415889-25-023589

Form Type

4

Issuer CIK

0001623526

Allan Jonathan's History

Date Ticker Type Value
2026-03-20 STOK $292K
2026-03-20 STOK $21K
2025-12-08 STOK $41K
2025-12-08 STOK $87K
2025-12-05 STOK $31K
2025-12-05 STOK $169K
2025-12-05 STOK $74K
2025-12-04 STOK $25K
2025-12-04 STOK $6K
2025-12-03 STOK $27K

Other Insiders at STOK (90d)

Insider Bought Sold Last
Ticho Barry
CHIEF MEDICAL OFFICER
$60K 2026-04-01
Kahn Clare 2026-04-03
Allan Jonathan
GENERAL COUNSEL & CORP SEC
$313K 2026-03-20